NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy.
Autor: | Rothan, Hussin A.1, Amini, Elham2, Faraj, Fadihl L.3, Golpich, Mojtaba2, Teoh, Teow Chong4, Gholami, Khadijeh5, Yusof, Rohana1 |
---|---|
Zdroj: | Scientific Reports. 3/31/2017, p45540. 1p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |